In Vitro Determination of Hydrolytic Enzymes and Echinocandin Susceptibility in Mexican Clinical Isolates of Candida glabrata Sensu Stricto

被引:0
|
作者
Trevino-Rangel, Rogelio de J. [1 ]
Espinosa-Perez, Jose F. [1 ]
Villanueva-Lozano, Hiram [1 ]
Soto-Quintana, Laura A. [1 ]
Montoya, Alexandra M. [1 ]
Luna-Rodriguez, Carolina E. [1 ]
Gonzalez, Gloria M. [1 ]
机构
[1] Univ Autonoma Nuevo Leon, Fac Med, Dept Microbiol, Monterrey, Nuevo Leon, Mexico
关键词
Candida glabrata; Phospholipases; Aspartyl Proteinases; Esterases; Hemolysins; Echinocandins; VIRULENCE FACTORS; ANTIFUNGAL SUSCEPTIBILITY; PHOSPHOLIPASE; PROTEINASE; HEMOLYSIN; BRACARENSIS; EXPRESSION; COAGULASE; ESTERASE; EXHIBIT;
D O I
10.5812/jjm.85092
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Candida glabrata is an opportunistic yeast that has emerged as a cause of human fungal disease, and is a complex of three closely related species. Until now, there is not enough information about its virulence attributes. Moreover, its resistance to echinocandins has been documented, which is a cause of clinical concern. Objectives: The objective of this study was to evaluate the in vitro production of aspartyl proteinase, phospholipase, esterase, hemolysin, DNase, and coagulase in a subset of 107 Mexican clinical isolates of C. glabrata sensu stricto, as well as to determinate its echinocandin susceptibility. Methods: The enzymatic determinations were carried out in plate assays using specific substrates, excepting coagulase, which was determined by the classic tube test. Antifungal susceptibility testing was determined in accordance with the CLSI broth microdilution method. Results: Aspartyl proteinase, hemolysin, and phospholipase were detected in 100%, 95%, and 79% of isolates, respectively. Blood isolates were associated with a very strong activity of aspartyl proteinase and hemolysin, and those recovered from vaginal swabs were associated with very strong production of aspartyl proteinase, phospholipase, and hemolysin. All isolates were susceptible to echinocandins, except one bloodstream isolate, which was resistant to echinocandins. Conclusions: A very strong activity of aspartyl proteinase and hemolysin was particularly associated with both, bloodstream, and vaginal swab isolates. Echinocandin resistance was rare.
引用
下载
收藏
页数:6
相关论文
共 50 条
  • [21] Biodiversity, virulence factors and antifungal susceptibility of clinical isolates of Candida parapsilosis sensu lato
    Ortega-Riveros, M.
    Miranda-Zapico, I.
    Eraso, E.
    Quindos, G.
    MYCOSES, 2009, 52 : 55 - 55
  • [22] Usefulness of a multiplex PCR for the rapid identification of Candida glabrata species complex in Mexican clinical isolates
    del Rocio Reyes-Montes, Maria
    Acosta-Altamirano, Gustavo
    Duarte-Escalante, Esperanza
    Garcia Salazar, Eduardo
    Martinez-Herrera, Erick
    Arenas, Roberto
    Gonzalez, Gloria
    Guadalupe Frias-De-Leon, Maria
    REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO, 2019, 61
  • [23] Susceptibility in vitro of clinical Candida albicans isolates to the selected azoles
    Pawlicki, Bartlomiej
    Biernasiuk, Anna
    Jonczyk, Monika
    Malm, Anna
    CURRENT ISSUES IN PHARMACY AND MEDICAL SCIENCES, 2021, 34 (02) : 77 - 80
  • [24] In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei
    M. Drago
    M. M. Scaltrito
    G. Morace
    European Journal of Clinical Microbiology and Infectious Diseases , 2004, 23 : 619 - 624
  • [25] In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei
    Drago, M
    Scaltrito, MM
    Morace, G
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (08) : 619 - 624
  • [26] In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles
    Perea, S
    Gonzalez, G
    Fothergill, AW
    Sutton, DA
    Rinaldi, MG
    JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (05) : 1831 - 1833
  • [27] In vitro synergy with fluconazole plus doxycycline or tigecycline against clinical Candida glabrata isolates
    Hooper, Randol W.
    Ashcraft, Deborah S.
    Pankey, George A.
    MEDICAL MYCOLOGY, 2019, 57 (01) : 122 - 126
  • [28] Increasing Trends of Reduced Susceptibility to Antifungal Drugs Among Clinical Candida glabrata Isolates in Kuwait
    Khan, Ziauddin
    Ahmad, Suhail
    Al-Sweih, Noura
    Mokaddas, Eiman
    Al-Banwan, Khalifa
    Alfouzan, Wadha
    Al-Obaid, Inaam
    Al-Obaid, Khaled
    Varghese, Soumya
    MICROBIAL DRUG RESISTANCE, 2020, 26 (08) : 982 - 990
  • [29] Whole genome analysis of echinocandin non-susceptible Candida Glabrata clinical isolates: a multi-center study in China
    Yi Li
    Xin Hou
    Ruoyu Li
    Kang Liao
    Ling Ma
    Xiaoming Wang
    Ping Ji
    Haishen Kong
    Yun Xia
    Hui Ding
    Wei Kang
    Ge Zhang
    Jin Li
    Meng Xiao
    Yingxing Li
    Yingchun Xu
    BMC Microbiology, 23
  • [30] Whole genome analysis of echinocandin non-susceptible Candida Glabrata clinical isolates: a multi-center study in China
    Li, Yi
    Hou, Xin
    Li, Ruoyu
    Liao, Kang
    Ma, Ling
    Wang, Xiaoming
    Ji, Ping
    Kong, Haishen
    Xia, Yun
    Ding, Hui
    Kang, Wei
    Zhang, Ge
    Li, Jin
    Xiao, Meng
    Li, Yingxing
    Xu, Yingchun
    BMC MICROBIOLOGY, 2023, 23 (01)